Marina Ruiz-Piñero (Marina Ruiz)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 6

Top Topics

Placebo Controlled

Clinical Practice

Ejection Fraction

Top Venues

Expert review of neurotherapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

David Garcia Azorin, Blanca Martínez, María Gutiérrez, Marina Ruiz-Piñero, Ana Echavarría, Álvaro Sierra, Ángel Luis Guerrero-Peral
Real-World Evaluation of the Tolerability to Onabotulinum Toxin A: The RETO Study. Toxins 14 (12) (2022)
David Garcia Azorin, Blanca Martínez, María Gutiérrez, Marina Ruiz-Piñero, Ana Echavarría, Álvaro Sierra, Ángel Luis Guerrero-Peral
Real-World Evaluation of the Tolerability to Onabotulinum Toxin A: The RETO Study. Toxins 14 (12) (2022)
David Garcia Azorin, Blanca Martínez, María Gutiérrez, Marina Ruiz-Piñero, Ana Echavarría, Álvaro Sierra, Ángel Luis Guerrero-Peral
Real-World Evaluation of the Tolerability to Onabotulinum Toxin A: The RETO Study. Toxins 14 (12) (2022)
David Garcia Azorin, Blanca Martínez, María Gutiérrez, Marina Ruiz-Piñero, Ana Echavarría, Álvaro Sierra, Ángel Luis Guerrero-Peral
Real-World Evaluation of the Tolerability to Onabotulinum Toxin A: The RETO Study. Toxins 14 (12) (2022)
David Garcia Azorin, Blanca Martínez, María Gutiérrez, Marina Ruiz-Piñero, Ana Echavarría, Álvaro Sierra, Ángel Luis Guerrero-Peral
Real-World Evaluation of the Tolerability to Onabotulinum Toxin A: The RETO Study. Toxins 14 (12) (2022)
Enrique Martínez-Pías, David Garcia Azorin, Ane Mínguez-Olaondo, Javier Trigo López, Álvaro Sierra, Marina Ruiz-Piñero, Ángel Luis Guerrero-Peral
Triptanophobia in migraine: A case-control study on the causes and consequences of the nonuse of triptans in chronic migraine patients. Expert review of neurotherapeutics 21 (1) (2020)